drugset
drugset / Trial / NCT00959881

Study Evaluating The Coadministration of Begacestat And Donepezil

NCT00959881 ↗

Phase 1 Completed 47 enrolled Wyeth is now a wholly owned subsidiary of Pfizer Pfizer · collab
RandomizedParallel-groupDouble-blindBasic science

Summary

This study examines the cardiac effects (effects on the heart) of administering donepezil and begacestat together to healthy subjects.

Timeline

Start
2009-08
Primary completion
2009-11
Completion
2009-11

Drugs

EvaluationDrugModalityDoseRoute
Subject Begacestat Small molecule 300 mg —
Background Donepezil Small molecule 5 mg —
Background Donepezil Small molecule 10 mg —

Indications

No indication recorded.